{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:44:50Z","timestamp":1788356690324,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.anpedi.2009.11.020","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T04:36:50Z","timestamp":1266208610000},"page":"221.e1-221.e33","source":"Crossref","is-referenced-by-count":26,"title":["Conferencia de Consenso sobre bronquiolitis aguda (I): metodolog\u00eda y recomendaciones"],"prefix":"10.1016","volume":"72","author":[{"given":"J.","family":"Gonz\u00e1lez de Dios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ochoa Sangrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2009.11.020_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archpedi.1983.02140270007003","article-title":"Bronchiolitis. What's in the name?","volume":"137","author":"McConnochie","year":"1983","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.anpedi.2009.11.020_bib2","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez de Dios J, Ochoa Sangrador C, y Grupo Investigador del Proyecto aBREVIADo. Estudio de variabilidad en el manejo de la bronquiolitis aguda en Espa\u00f1a en relaci\u00f3n con la edad de los pacientes. Estudio multic\u00e9ntrico nacional (Proyecto aBREVIADo). An Pediatr (Barc). 2010; 72: 4\u201318.","DOI":"10.1016\/j.anpedi.2009.10.006"},{"key":"10.1016\/j.anpedi.2009.11.020_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1157\/13124223","article-title":"Consenso multidisciplinar espa\u00f1ol sobre la profilaxis de la infecci\u00f3n respiratoria pedi\u00e1trica por virus respiratorio sincitial","volume":"69","author":"Figueras Aloy","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.11.020_bib4","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1542\/peds.2008-2867","article-title":"Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis","volume":"123","author":"Castro-Rodr\u00edguez","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1695-4033(02)77805-3","article-title":"Quimioprofilaxis con palivizumab en Andaluc\u00eda. Resultados de la epidemia de VRS 2000\u20132001","volume":"56","year":"2002","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/jp.2008.37","article-title":"Strategies for prevention of RSV nosocomial infection","volume":"28","author":"Groothuis","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.anpedi.2009.11.020_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00006454-199705000-00004","article-title":"Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases","volume":"16","author":"Kimpen","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib8","unstructured":"New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ. 2003;169:207\u20138."},{"key":"10.1016\/j.anpedi.2009.11.020_bib9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.11.020_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.11.020_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.11.020_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Schunemann","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.11.020_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.pec.0000161469.19841.86","article-title":"Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation","volume":"21","author":"Mansbach","year":"2005","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.anpedi.2009.11.020_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1695-4033(00)77494-7","article-title":"Antecedentes perinatales y hospitalizaci\u00f3n por bronquiolitis","volume":"53","author":"Bonillo Perales","year":"2000","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00006454-200109000-00010","article-title":"Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons","volume":"20","author":"Carbonell-Estrany","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1017\/S0950268805005571","article-title":"Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain","volume":"134","author":"Cilla","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.anpedi.2009.11.020_bib17","first-page":"1774","article-title":"American Academy of Pediatrics (AAP) Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib18","unstructured":"SIGN. Bronchiolitis in children. A national clinical guideline. Available at: http:\/\/www.sign.ac.uk. 2006."},{"key":"10.1016\/j.anpedi.2009.11.020_bib19","unstructured":"Bronchiolitis Guideline Team, Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants year of age or less presenting with a first time episode. Cincinnati: Cincinnati Children's Hospital Medical Center; 2005. [cited 22 August 2006]. Available from url: http:\/\/www.cincinnatichildrens.org\/NR\/rdonlyres\/0B7B99D7-DB3E-4186-B2FC-71539E23421E\/0\/bronchiolitisguideline.pdf."},{"key":"10.1016\/j.anpedi.2009.11.020_bib20","unstructured":"National Guideline Clearinghouse (NGC). Guideline Synthesis. Prevention, diagnosis and treatment of pediatric bronchiolitis. [en l\u00ednea] [fecha de consulta: 09\/05\/2009]. Disponible en: http:\/\/www.guideline.gov\/Compare\/comparison.aspx?file=BRONCHIOLITIS1.inc."},{"key":"10.1016\/j.anpedi.2009.11.020_bib21","doi-asserted-by":"crossref","unstructured":"Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2004:CD003123.","DOI":"10.1002\/14651858.CD003123.pub2"},{"key":"10.1016\/j.anpedi.2009.11.020_bib22","doi-asserted-by":"crossref","unstructured":"Spurling GK, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2007:CD005189.","DOI":"10.1002\/14651858.CD005189.pub2"},{"key":"10.1016\/j.anpedi.2009.11.020_bib23","series-title":"Broncodilatadores para la bronquiolitis (Revisi\u00f3n Cochrane traducida). La Biblioteca Cochrane Plus","article-title":"Broncodilatadores para la bronquiolitis","author":"Gadomski","year":"2007"},{"key":"10.1016\/j.anpedi.2009.11.020_bib24","first-page":"CD001266","article-title":"Bronchodilators for bronchiolitis","author":"Kellner","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib25","first-page":"CD001279","article-title":"Anticholinergic drugs for wheeze in children under the age of two years","author":"Everard","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib26","first-page":"CD001279","article-title":"Anticholinergic drugs for wheeze in children under the age of two years","author":"Everard","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib27","first-page":"CD004878","article-title":"WITHDRAWN: Glucocorticoids for acute viral bronchiolitis in infants and young children","author":"Patel","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib28","first-page":"CD004878","article-title":"Glucocorticoids for acute viral bronchiolitis in infants and young children","author":"Patel","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib29","first-page":"CD001107","article-title":"Inhaled steroids for episodic viral wheeze of childhood","author":"McKean","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib30","first-page":"CD004881","article-title":"Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing","author":"Blom","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib31","first-page":"CD004873","article-title":"Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old","author":"Perrotta","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib32","first-page":"CD004873","article-title":"Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old","author":"Perrotta","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib33","first-page":"CD001725","article-title":"WITHDRAWN: Immunoglobulin for preventing respiratory syncytial virus infection","author":"Wang","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib34","first-page":"CD001725","article-title":"Immunoglobulin for preventing respiratory syncytial virus infection","author":"Wang","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib35","first-page":"CD004883","article-title":"Immunoglobulin treatment for respiratory syncytial virus infection","author":"Fuller","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib36","first-page":"CD000181","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","volume":"1","author":"Ventre","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib37","first-page":"CD000181","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","volume":"4","author":"Ventre","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib38","first-page":"CD006458","article-title":"Nebulized hypertonic saline solution for acute bronchiolitis in infants","author":"Zhang","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.anpedi.2009.11.020_bib39","first-page":"CD005150","article-title":"Surfactant therapy for bronchiolitis in critically ill infants","volume":"3","author":"Ventre","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib40","first-page":"1","article-title":"Management of bronchiolitis in infants and children","author":"Viswanathan","year":"2003","journal-title":"Evid Rep Technol Assess (Summ)"},{"issue":"Suppl 1","key":"10.1016\/j.anpedi.2009.11.020_bib41","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.prrv.2006.04.161","article-title":"Current pharmacological treatments for bronchiolitis are useless. The case for the con's","volume":"7","author":"Landau","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.anpedi.2009.11.020_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archpedi.159.2.196","article-title":"Do we really need more trials about the efficacy of commonly used treatments for bronchiolitis?","volume":"159","author":"Barbi","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2007.05.041","article-title":"Acute viral bronchiolitis: to treat or not to treat-that is the question","volume":"151","author":"Calogero","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib44","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1056\/NEJMoa0900544","article-title":"Epinephrine and dexamethasone in children with bronchiolitis","volume":"360","author":"Plint","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1542\/peds.79.6.939","article-title":"Wheezing in infants: the response to epinephrine","volume":"79","author":"Lowell","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1067\/mpd.2002.120271","article-title":"Efficacy of oral dexamethasone in outpatients with acute bronchiolitis","volume":"140","author":"Schuh","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa071255","article-title":"A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis","volume":"357","author":"Corneli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1067\/S0022-3476(03)00498-0","article-title":"Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial","volume":"143","author":"Csonka","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib49","first-page":"137","article-title":"Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections","volume":"97","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib50","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archpedi.1996.02170340056011","article-title":"Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview","volume":"150","author":"Randolph","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5694\/j.1326-5377.2004.tb05993.x","article-title":"Bronchiolitis: assessment and evidence-based management","volume":"180","author":"Fitzgerald","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.anpedi.2009.11.020_bib52","first-page":"285","article-title":"Bronchiolitis","volume":"4","author":"Lozano","year":"2005","journal-title":"Clin Evid"},{"key":"10.1016\/j.anpedi.2009.11.020_bib53","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/archpedi.1997.02170490033006","article-title":"Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis","volume":"151","author":"Kuppermann","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00006454-200102000-00019","article-title":"Misuse of antimicrobials in children with asthma and bronchiolitis: a review","volume":"20","author":"Henderson","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.1.5479.83","article-title":"Antibiotic treatment of epidemic bronchiolitis\u2014a double-blind trial","author":"Field","year":"1966","journal-title":"British Medical Journal"},{"key":"10.1016\/j.anpedi.2009.11.020_bib56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/adc.59.11.1038","article-title":"Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study","volume":"59","author":"Friis","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.11.020_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1183\/09031936.00029206","article-title":"Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial","volume":"29","author":"Tahan","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib58","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1378\/chest.122.6.2015","article-title":"Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms","volume":"122","author":"Sarrell","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.anpedi.2009.11.020_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1378\/chest.123.2.481","article-title":"Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis","volume":"123","author":"Mandelberg","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.anpedi.2009.11.020_bib60","first-page":"169","article-title":"Hypertonic saline\/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience","volume":"8","author":"Tal","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jpeds.2007.04.010","article-title":"Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants","volume":"151","author":"Kuzik","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199603000-00007","article-title":"Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants","author":"Rimensberger","year":"1996","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.anpedi.2009.11.020_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00000542-196805000-00008","article-title":"Acute respiratory failure in infants with bronchiolitis","volume":"29","author":"Downes","year":"1968","journal-title":"Anesthesiology"},{"key":"10.1016\/j.anpedi.2009.11.020_bib64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/003693300304800404","article-title":"Respiratory syncytial virus bronchiolitis in ex-preterm infants in the Scottish highlands: review of hospital admissions and an analysis of hospital cost","volume":"48","author":"Zaw","year":"2003","journal-title":"Scott Med J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib65","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/adc.64.10.1431","article-title":"Respiratory failure and mechanical ventilation in severe bronchiolitis","volume":"64","author":"Lebel","year":"1989","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.11.020_bib66","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bmj.283.6305.1506","article-title":"Continuous positive airway pressure in bronchiolitis","volume":"283","author":"Beasley","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.anpedi.2009.11.020_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ppul.1950160305","article-title":"Continuous positive airway pressure by nasal prongs in bronchiolitis","volume":"16","author":"Soong","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.11.020_bib68","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/adc.2003.039404","article-title":"Review of treatment of bronchiolitis related apnoea in two centres","volume":"90","author":"Al-balkhi","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.11.020_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/rmed.1999.0578","article-title":"High-frequency oscillatory ventilation in RSV bronchiolitis patients","volume":"93","author":"Duval","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00431-004-1580-0","article-title":"Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation","volume":"164","author":"Flamant","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/fn.73.2.F91","article-title":"Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report","volume":"73","author":"Khan","year":"1995","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.anpedi.2009.11.020_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/adc.2005.091231","article-title":"Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis","volume":"93","author":"Thia","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.11.020_bib73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1542\/peds.109.1.68","article-title":"Heliox therapy in infants with acute bronchiolitis","volume":"109","author":"Martin\u00f3n-Torres","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.anpedi.2008.08.001","article-title":"Heliox como fuente de nebulizaci\u00f3n del tratamiento broncodilatador en lactantes con bronquiolitis","volume":"70","author":"Iglesias Fern\u00e1ndez","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.11.020_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00130478-200207000-00011","article-title":"Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure","volume":"3","author":"Luchetti","year":"2002","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib76","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1399-6576.1998.tb05326.x","article-title":"Porcine-derived surfactant treatment of severe bronchiolitis","volume":"42","author":"Luchetti","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.anpedi.2009.11.020_bib77","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/ajrccm.162.4.9909004","article-title":"Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis","volume":"162","author":"Tibby","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib78","first-page":"A340","article-title":"A comparison of the effects of nebulized albuterol, L-epinephrine, and saline on the pulmonary mechanics in RSV bronchiolitis [abstract]","author":"Wankum","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.anpedi.2009.11.020_bib79","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/0140-6736(92)92534-M","article-title":"Virus induced apnoea and theophylline","volume":"340","author":"Johnston","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2009.11.020_bib80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5694\/j.1326-5377.1979.tb125719.x","article-title":"Respiratory syncytial virus with apnoea treated with theophylline","volume":"2","author":"DeBuse","year":"1979","journal-title":"Med J Aust"},{"key":"10.1016\/j.anpedi.2009.11.020_bib81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1378\/chest.120.1.203","article-title":"Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis","volume":"120","author":"Nasr","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.anpedi.2009.11.020_bib82","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/adc.69.4.440","article-title":"Treatment of respiratory sycytial virus infection with recombinant interferon alfa-2A","author":"Sung","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.11.020_bib83","doi-asserted-by":"crossref","first-page":"b897","DOI":"10.1136\/bmj.b897","article-title":"The effect of high dose inhaled corticosteroids on wheeze in infants alter respiratory syncytial virus infection: randomised double blind placebo controlled trial","volume":"338","author":"Ermers","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.11.020_bib84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.200207-747OC","article-title":"A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis","volume":"167","author":"Bisgaard","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.200706-910OC","article-title":"Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children","volume":"178","author":"Bisgaard","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199501193320301","article-title":"Asthma and wheezing in the first six years of life","volume":"332","author":"Martinez","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1067\/mai.2003.162","article-title":"Tucson Children's Respiratory Study: 1980 to present","volume":"111","author":"Taussig","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anpedi.2009.11.020_bib88","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm.162.4.9912111","article-title":"A Clinical Index to define risk of asthma in young children with recurrent wheezing","volume":"162","author":"Castro-Rodr\u00edguez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib89","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2004.09.020","article-title":"Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma","volume":"114","author":"Guilbert","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anpedi.2009.11.020_bib90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1542\/peds.99.1.93","article-title":"Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis","volume":"99","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib91","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib92","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib93","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1542\/peds.108.4.1000","article-title":"Uncertainty in the management of viral lower respiratory tract disease","volume":"108","author":"Meissner","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib94","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib95","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","article-title":"Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants","volume":"22","author":"Pedraz","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib96","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/S104795110700042X","article-title":"Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study","volume":"17","author":"Medrano","year":"2007","journal-title":"Cardiol Young"},{"key":"10.1016\/j.anpedi.2009.11.020_bib97","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.inf.0000069768.34383.18","article-title":"Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants","volume":"22","author":"Singleton","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib98","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/01.inf.0000245104.26996.57","article-title":"Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season","volume":"25","author":"Singleton","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.inf.0000105106.93562.d3","article-title":"Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002","volume":"23","author":"Henckel","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00002018-200326040-00005","article-title":"Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection","volume":"26","author":"Lacaze-Masmonteil","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.anpedi.2009.11.020_bib101","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ppul.20507","article-title":"Beyond randomized controlled trials: a \u201creal life\u201d experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab","volume":"41","author":"Mitchell","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.11.020_bib102","doi-asserted-by":"crossref","first-page":"F286","DOI":"10.1136\/adc.2004.058081","article-title":"Palivizumab for preterm infants. Is it worth it?","volume":"90","author":"Embleton","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.anpedi.2009.11.020_bib103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14737167.7.5.445","article-title":"Cost-effectiveness of palivizumab in infancy","volume":"7","author":"Embleton","year":"2007","journal-title":"Expert Review of Pharmacoeconomics and Outcomes Research"},{"key":"10.1016\/j.anpedi.2009.11.020_bib104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-3038.2007.00610.x","article-title":"Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization","volume":"19","author":"Chen","year":"2008","journal-title":"Pediatric Allergy and Immunology"},{"key":"10.1016\/j.anpedi.2009.11.020_bib105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archpedi.156.10.1034","article-title":"Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review","volume":"156","author":"Kamal-Bahl","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2009.11.020_bib106","first-page":"17","article-title":"Palivizumab prophylaxis against respiratory syncytial virus","author":"Dunfield","year":"2007","journal-title":"Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH)"},{"key":"10.1016\/j.anpedi.2009.11.020_bib107","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0149-2918(00)83032-5","article-title":"Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis","volume":"22","author":"Lofland","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.anpedi.2009.11.020_bib108","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1345\/aph.10374","article-title":"A cost-benefit analysis of RSV prophylaxis in high-risk infants","volume":"35","author":"Schrand","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anpedi.2009.11.020_bib109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200204000-00006","article-title":"Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina","volume":"21","author":"Farina","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.11.020_bib110","first-page":"188","article-title":"Cost-efficcy analysis of palivizumab in the prevention of respiratory syncytial virus infections in young children with hemodynamically significant congenital heart disease. I","volume":"31","author":"Chiroli","year":"2005","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib111","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1157\/13092505","article-title":"La eficiencia (coste-efectividad) de palivizumab como profilaxis para la infecci\u00f3n por virus respiratorio sincitial en prematuros de 32\u201335 semanas en Espa\u00f1a","volume":"65","author":"Lazaro y de Mercado","year":"2006","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.11.020_bib112","first-page":"59","article-title":"Cost-effectiveness of palivizumab in preventing respiratory syncytial virus in premature infants and children with chronic lung disease in Spain","volume":"4","author":"Lazaro Y De Mercado","year":"2007","journal-title":"Pharmacoeconomics-Spanish Research Articles"},{"key":"10.1016\/j.anpedi.2009.11.020_bib113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00019053-200725010-00006","article-title":"Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis","volume":"25","author":"Nuijten","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib114","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1824-7288-35-4","article-title":"Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncyial virus infection (RSV) among high-risk preterm infants","volume":"35","author":"Chirico","year":"2009","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.anpedi.2009.11.020_bib115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/peds.104.3.419","article-title":"Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants","volume":"104","author":"Joffe","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.11.020_bib116","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1440-1754.2000.00303.x","article-title":"Outcome of respiratory syncytial virus infection and a cost-benefit analysis of prophylaxis","volume":"36","author":"Numa","year":"2000","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.anpedi.2009.11.020_bib117","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1440-1754.2002.00790.x","article-title":"Cost-effectiveness of palivizumab in New Zealand","volume":"38","author":"Vogel","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.anpedi.2009.11.020_bib118","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1542\/peds.2004-0224","article-title":"Economic analysis of palivizumab in infants with congenital heart disease","volume":"114","author":"Yount","year":"2004","journal-title":"Pediatrics"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T03:25:07Z","timestamp":1685417107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403310000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1695403310000032"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2009.11.020","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}